Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXP32O
|
||||
| Drug Name |
(+/-)-5-(2-amino-2-oxo-ethyl)-4-oxo-N-[(3-oxo-4H-1,4-benzoxazin-6-yl)methyl]-5,6,7,8-tetrahydro-3H-benzothiopheno[2,3-d]pyrimidine-2-carboxamide
|
||||
| Synonyms |
CHEMBL460899
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H21N5O5S
|
||||
| Canonical SMILES |
NC(=O)CC1CCCc2sc3N=C(NC(=O)c3c12)C(=O)NCc4ccc5OCC(=O)Nc5c4
|
||||
| InChI |
InChI=1S/C22H21N5O5S/c23-15(28)7-11-2-1-3-14-17(11)18-20(30)26-19(27-22(18)33-14)21(31)24-8-10-4-5-13-12(6-10)25-16(29)9-32-13/h4-6,11H,1-3,7-9H2,(H2,23,28)(H,24,31)(H,25,29)(H,26,27,30)
|
||||
| InChIKey |
ITADELAVAWJACR-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Collagenase 3 | Target Info | [1587926] | ||
| Neutrophil collagenase | Target Info | [1587926] | |||
| NetPath Pathway | IL1 Signaling Pathway | ||||
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.